The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125375871 12537587 1 I 20160622 20160707 20160707 EXP CA-HQ SPECIALTY-CA-2016INT000467 INTERCHEM 36.00 YR M Y 0.00000 20160707 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125375871 12537587 1 PS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Oral UNK N 201749
125375871 12537587 2 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 20 MG N 201749 20 MG
125375871 12537587 3 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 Subcutaneous 3.5714 MG (25 MG, 1 IN 1 W) N 201749 25 MG
125375871 12537587 4 SS ENBREL ETANERCEPT 1 Subcutaneous 50 MG, 1 W N 0 50 MG
125375871 12537587 5 SS PLAQUENIL /00072602/ HYDROXYCHLOROQUINE DIPHOSPHATE 1 200 MG N 0 200 MG
125375871 12537587 6 SS SULFASALAZINE. SULFASALAZINE 1 Oral 1000 MG (500 MG, 2 IN 1 D) N 0 500 MG
125375871 12537587 7 SS SULFASALAZINE. SULFASALAZINE 1 2000 MG (1000 MG, 2 IN 1 D) N 0 1000 MG
125375871 12537587 8 SS HUMIRA ADALIMUMAB 1 2.8571 MG (40 MG, 1 IN 2 W) N 0 40 MG
125375871 12537587 9 SS RITUXAN RITUXIMAB 1 0.0111 G (2 G, 1 IN 6 MO) N 0 2 G
125375871 12537587 10 SS LEFLUNOMIDE. LEFLUNOMIDE 1 10 MG (10 MG, 1 IN 1 D) N 0 10 MG
125375871 12537587 11 SS ACTEMRA TOCILIZUMAB 1 UNK N 0
125375871 12537587 12 SS ORENCIA ABATACEPT 1 UNK N 0
125375871 12537587 13 SS GOLD GOLD 1 UNK N 0 INJECTION
125375871 12537587 14 SS PREDNISONE. PREDNISONE 1 20 MG, 1 D U 0 20 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125375871 12537587 1 Rheumatoid arthritis
125375871 12537587 4 Rheumatoid arthritis
125375871 12537587 5 Rheumatoid arthritis
125375871 12537587 6 Rheumatoid arthritis
125375871 12537587 8 Rheumatoid arthritis
125375871 12537587 9 Rheumatoid arthritis
125375871 12537587 10 Rheumatoid arthritis
125375871 12537587 11 Rheumatoid arthritis
125375871 12537587 12 Rheumatoid arthritis
125375871 12537587 13 Rheumatoid arthritis
125375871 12537587 14 Pain

Outcome of event

Event ID CASEID OUTC COD
125375871 12537587 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125375871 12537587 Activities of daily living impaired
125375871 12537587 Drug ineffective
125375871 12537587 Infection
125375871 12537587 Insomnia
125375871 12537587 Rheumatoid arthritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125375871 12537587 2 200606 0
125375871 12537587 4 200612 200704 0
125375871 12537587 5 200411 200702 0
125375871 12537587 6 200612 0
125375871 12537587 7 200704 0
125375871 12537587 8 200706 200712 0
125375871 12537587 9 200807 200902 0
125375871 12537587 10 200902 0
125375871 12537587 13 201408 201501 0